Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
Shunan Zhang, Yi Lai, Jiaxing Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 22

Showing 22 citing articles:

Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models
Ye Liu, Haiyang Wang, Mengchao Ding, et al.
Nano Letters (2024) Vol. 24, Iss. 28, pp. 8741-8751
Closed Access | Times Cited: 7
A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer
Yuan Zhang, Wei Gu, Chen Wan, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7897-7907
Closed Access
Chemical modulation of the tumor microenvironment enabled by nanomaterials for enhanced cancer treatment
Yifan Yan, Lei Zhang, Liangzhu Feng
Cell Reports Physical Science (2025), pp. 102452-102452
Open Access
Recent Progress in Radiosensitive Nanomaterials for Radiotherapy-Triggered Drug Release
Renfeng Jiang, Qiong Fang, Wenjun Liu, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Integrating high-Z elements and multilayer structures into composite films with interlayer scattering effects for high-energy X-ray shielding
Haiyang Du, YU Hai-peng, Daniel K. Macharia, et al.
Journal of Colloid and Interface Science (2025) Vol. 689, pp. 137195-137195
Closed Access
Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy
Xingyu Jiang, Yi Lai, Wenzheng Xia, et al.
Advanced Materials (2025)
Open Access
Dual‐Functional Hafnium Oxide Nanoplatform Combining High‐Z Radiosensitization With Bcl‐2 Gene Silencing for Enhanced Cancer Radiotherapy
Seungyong Shin, Ga‐Hyun Bae, Jun‐Hyeok Han, et al.
Advanced Healthcare Materials (2025)
Open Access
Dopant‐Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy
Linhong Zhong, Xun Guo, Liming Deng, et al.
Advanced Science (2025)
Open Access
PROTAC-loaded nanocapsules degrading BRD4 for radio-chemotherapy sensitization in glioblastoma
Yun Guo, Mingzhu Fang, Shilin Zhang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Epigenetically elevated RAD51AP1 regulates the RAD51–UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma
Yuanhao Chang, Jingchen Yang, Zhuo Li, et al.
Chinese Medical Journal (2025)
Open Access
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma
Hong‐Shuai Li, Ruiyi Tang, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review)
Voraporn Yongprayoon, Napasporn Wattanakul, Winnada Khomate, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
A photoactivatable upconverting nanodevice boosts the lysosomal escape of PROTAC degraders for enhanced combination therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 2
Nanomaterials for enhanced X‐ray‐triggered cancer therapy: Progress and prospects
Yuanchun Chen, Shijie Shangguan, Zhongyu Lin, et al.
BMEMat (2024)
Open Access | Times Cited: 2
Emerging nanoradiosensitizers and nanoradioprotectants for enhanced cancer theranostics
Lin Zhao, Yang Sun, Qinrui Fu, et al.
Chemical Engineering Journal (2024) Vol. 501, pp. 157554-157554
Closed Access | Times Cited: 2
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Dual‐Enhanced Nanohybrids for Synergistic Photothermal and Photodynamic Therapy in Cancer Treatment with Immune Checkpoint Inhibitors
Dabin Lee, Hyungjin Sun, Jieun Bang, et al.
Advanced Healthcare Materials (2024)
Closed Access
Remotely Sequential Activation of Biofunctional MXenes for Spatiotemporally Controlled Photothermal Cancer Therapy Integrated with Multimodal Imaging
Jing Jia, Xiaobo Zhang, Yiran Li, et al.
Small (2024)
Closed Access
Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie (2024)
Closed Access
Page 1

Scroll to top